Scientific DirectorAbbVieLong Grove, IL, U.S.
Disclosure(s): AbbVie: Employee (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)
Elagolix Improves Low Hemoglobin in Women With Uterine Fibroid-Associated Heavy Menstrual Bleeding: Post Hoc Analysis of Elaris UF-1 and UF-2 - F-07
Saturday, May 20, 20238:00 AM – 9:00 AM ET
Elagolix With Add-Back Therapy Improves Hemoglobin Concentration in Women With Fibroid-Associated Heavy Menstrual Bleeding Across Subgroups: Post Hoc Analysis of Elaris UF-1 and UF-2 - F-08
